https://www.selleckchem.com/products/gsk269962.html In the article "Religiously/Spiritually Involved, but in Doubt or Disbelief-Why? Healthy?", Mrdjenovich (in J Relig Health https//doi.org/10.1007/s10943-018-0711-2 , 2018) explored the practices of religious attendance and prayer among atheists and agnostic theists. Speed et al. (in J Relig Health https//doi.org/10.1007/s10943-020-01109-1 , 2020) offered a commentary regarding Mrdjenovich's (2018) article with attention to moderators of associations between religious/spiritual constructs and health outcomes. In this rejoinder, I review Speed et al.'s (2020) commentary and I identify a number of concerns, both with their observations and ostensive oversights involving qualitative research methodology, the utility of survey data, the domain of belief, and the impact of calls for a pluralistic approach in the religion-heath research field. I conclude that Mrdjenovich does not misunderstand mechanisms of the (non)religion-health relationship as much as Speed et al. seem to misinterpret Mrdjenovich's (2018) purpose, perspective, and default position on the issues. I reiterate that a concerted effort is required to study health outcomes among religious minorities.Fragile X syndrome (FXS) is a genetic neurodevelopmental syndrome characterized by increased anxiety, repetitive behaviors, social communication deficits, delayed language development, and abnormal sensory processing. Recently, we have identified electroencephalographic (EEG) biomarkers that are conserved between the mouse model of FXS (Fmr1 KO mice) and humans with FXS. In this study, we test a specific candidate mechanism for engagement of multielectrode array (MEA) EEG biomarkers in the FXS mouse model. We administered TAK-063, a potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor, to Fmr1 KO mice, and examined its effects on MEA EEG biomarkers. We demonstrate significant dose-related amelioration of inter-trial phase coherence (ITPC